Company Performance Metrics
Brad Younggren: Co-Founder and CEOPast Role: 98point6, Chief Medical Officer
Robbie Schwietzer: chief operations officerPast Role: Medbridge, Chief Operating Officer
Circulate provides Therapeutic Plasma Exchange (TPE) treatments that remove inflammatory and disease-related substances from the bloodstream. The company offers an end-to-end solution enabling clinics and doctors' offices to deliver fully managed TPE treatments without requiring specialized equipment or staff. Its proprietary technology is FDA
cleared and supported by clinical research, showing potential to slow age-related biological processes and treat autoimmune conditions. Circulate focuses on evidence-based approaches that allow patients to experience therapeutic effects relatively quickly compared to conventional treatments. The service integrates science, clinical management, and patient care to facilitate healthier aging and address age-related diseases.